Male fertility during and after immune checkpoint inhibitor therapy: a cross-sectional pilot study

Background - Immune checkpoint inhibitors (ICIs) are widely used and may induce long-term survival in various types of cancer. Yet, there is scarce evidence on potential effects on patient fertility and the necessity of cryopreservation before treatment onset. The aim of our study was to assess the...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Salzmann, Martin (VerfasserIn) , Tosev, Georgi (VerfasserIn) , Heck, Melanie (VerfasserIn) , Schadendorf, Dirk (VerfasserIn) , Maatouk, Imad (VerfasserIn) , Enk, Alexander (VerfasserIn) , Hartmann, Martin (VerfasserIn) , Hassel, Jessica C. (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 29 May 2021
In: European journal of cancer
Year: 2021, Jahrgang: 152, Pages: 41-48
ISSN:1879-0852
DOI:10.1016/j.ejca.2021.04.031
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.ejca.2021.04.031
Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S095980492100277X
Volltext
Verfasserangaben:Martin Salzmann, Georgi Tosev, Melanie Heck, Dirk Schadendorf, Imad Maatouk, Alexander H. Enk, Martin Hartmann, Jessica C. Hassel

MARC

LEADER 00000caa a2200000 c 4500
001 1772152374
003 DE-627
005 20240414193407.0
007 cr uuu---uuuuu
008 210930s2021 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.ejca.2021.04.031  |2 doi 
035 |a (DE-627)1772152374 
035 |a (DE-599)KXP1772152374 
035 |a (OCoLC)1341421651 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Salzmann, Martin  |d 1993-  |e VerfasserIn  |0 (DE-588)1193207150  |0 (DE-627)1671866436  |4 aut 
245 1 0 |a Male fertility during and after immune checkpoint inhibitor therapy  |b a cross-sectional pilot study  |c Martin Salzmann, Georgi Tosev, Melanie Heck, Dirk Schadendorf, Imad Maatouk, Alexander H. Enk, Martin Hartmann, Jessica C. Hassel 
264 1 |c 29 May 2021 
300 |a 8 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 30.09.2021 
520 |a Background - Immune checkpoint inhibitors (ICIs) are widely used and may induce long-term survival in various types of cancer. Yet, there is scarce evidence on potential effects on patient fertility and the necessity of cryopreservation before treatment onset. The aim of our study was to assess the prevalence of male infertility after initiation of ICI treatment. - Methods - This is a monocenter, cross-sectional pilot study. Fertility was investigated by spermiogram, analysis of sexual hormones and questionnaires on sexual function and sexual activity. Male patients under the age of 60 years previously or currently treated with ICI for cutaneous malignancies or uveal melanoma were included. - Results - Twenty-five patients were included, with a median age of 49 years. Eighteen of 22 (82%) available spermiograms showed no pathologies, all patients reported a normal sexual function and sexual activity. Of four patients with pathological spermiogram, three patients were diagnosed with azoospermia and one with oligoasthenoteratozoospermia. Three patients had significant confounding factors (previous inguinal radiotherapy, chemotherapy and chronic alcohol abuse, and bacterial orchitis). One patient with normal spermiogram before ICI treatment presented 1 year after initiation with azoospermia, showing an asymptomatic, inflammatory infiltrate with predominantly neutrophil granulocytes, macrophages and T-lymphocytes in the ejaculate. Infectious causes were ruled out; andrological examination was unremarkable. A second case with reduced sperm counts during treatment may be ICI-induced also. - Conclusions - Most patients had no restrictions in fertility, yet an inflammatory loss of spermatogenesis seems possible. Cryopreservation should be discussed with all patients with potential future desire for children before treatment. 
650 4 |a Adverse drug events 
650 4 |a Fertility 
650 4 |a Immune checkpoint inhibitor 
650 4 |a Spermatogenesis 
700 1 |a Tosev, Georgi  |e VerfasserIn  |0 (DE-588)1098138333  |0 (DE-627)857783084  |0 (DE-576)468966455  |4 aut 
700 1 |a Heck, Melanie  |e VerfasserIn  |0 (DE-588)1242204601  |0 (DE-627)1772153508  |4 aut 
700 1 |a Schadendorf, Dirk  |d 1960-  |e VerfasserIn  |0 (DE-588)11142576X  |0 (DE-627)499566076  |0 (DE-576)289702275  |4 aut 
700 1 |a Maatouk, Imad  |d 1979-  |e VerfasserIn  |0 (DE-588)1052002749  |0 (DE-627)787491357  |0 (DE-576)407672516  |4 aut 
700 1 |a Enk, Alexander  |d 1963-  |e VerfasserIn  |0 (DE-588)1032757140  |0 (DE-627)739272535  |0 (DE-576)166173517  |4 aut 
700 1 |a Hartmann, Martin  |d 1964-  |e VerfasserIn  |0 (DE-588)134168984  |0 (DE-627)562112952  |0 (DE-576)278491081  |4 aut 
700 1 |a Hassel, Jessica C.  |d 1975-  |e VerfasserIn  |0 (DE-588)129790702  |0 (DE-627)480399069  |0 (DE-576)29783715X  |4 aut 
773 0 8 |i Enthalten in  |t European journal of cancer  |d Amsterdam [u.a.] : Elsevier, 1992  |g 152(2021) vom: Juli, Seite 41-48  |w (DE-627)266883400  |w (DE-600)1468190-0  |w (DE-576)090954173  |x 1879-0852  |7 nnas  |a Male fertility during and after immune checkpoint inhibitor therapy a cross-sectional pilot study 
773 1 8 |g volume:152  |g year:2021  |g month:07  |g pages:41-48  |g extent:8  |a Male fertility during and after immune checkpoint inhibitor therapy a cross-sectional pilot study 
856 4 0 |u https://doi.org/10.1016/j.ejca.2021.04.031  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.sciencedirect.com/science/article/pii/S095980492100277X  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20210930 
993 |a Article 
994 |a 2021 
998 |g 129790702  |a Hassel, Jessica C.  |m 129790702:Hassel, Jessica C.  |d 910000  |d 911300  |d 50000  |e 910000PH129790702  |e 911300PH129790702  |e 50000PH129790702  |k 0/910000/  |k 1/910000/911300/  |k 0/50000/  |p 8  |y j 
998 |g 134168984  |a Hartmann, Martin  |m 134168984:Hartmann, Martin  |d 910000  |d 911300  |d 50000  |e 910000PH134168984  |e 911300PH134168984  |e 50000PH134168984  |k 0/910000/  |k 1/910000/911300/  |k 0/50000/  |p 7 
998 |g 1032757140  |a Enk, Alexander  |m 1032757140:Enk, Alexander  |d 910000  |d 911300  |e 910000PE1032757140  |e 911300PE1032757140  |k 0/910000/  |k 1/910000/911300/  |p 6 
998 |g 1052002749  |a Maatouk, Imad  |m 1052002749:Maatouk, Imad  |d 910000  |d 910600  |d 50000  |e 910000PM1052002749  |e 910600PM1052002749  |e 50000PM1052002749  |k 0/910000/  |k 1/910000/910600/  |k 0/50000/  |p 5 
998 |g 11142576X  |a Schadendorf, Dirk  |m 11142576X:Schadendorf, Dirk  |d 50000  |e 50000PS11142576X  |k 0/50000/  |p 4 
998 |g 1242204601  |a Heck, Melanie  |m 1242204601:Heck, Melanie  |d 50000  |e 50000PH1242204601  |k 0/50000/  |p 3 
998 |g 1098138333  |a Tosev, Georgi  |m 1098138333:Tosev, Georgi  |d 50000  |e 50000PT1098138333  |k 0/50000/  |p 2 
998 |g 1193207150  |a Salzmann, Martin  |m 1193207150:Salzmann, Martin  |d 910000  |d 911300  |e 910000PS1193207150  |e 911300PS1193207150  |k 0/910000/  |k 1/910000/911300/  |p 1  |x j 
999 |a KXP-PPN1772152374  |e 3982609410 
BIB |a Y 
SER |a journal 
JSO |a {"physDesc":[{"extent":"8 S."}],"recId":"1772152374","language":["eng"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"note":["Gesehen am 30.09.2021"],"title":[{"subtitle":"a cross-sectional pilot study","title_sort":"Male fertility during and after immune checkpoint inhibitor therapy","title":"Male fertility during and after immune checkpoint inhibitor therapy"}],"origin":[{"dateIssuedDisp":"29 May 2021","dateIssuedKey":"2021"}],"relHost":[{"recId":"266883400","disp":"Male fertility during and after immune checkpoint inhibitor therapy a cross-sectional pilot studyEuropean journal of cancer","origin":[{"dateIssuedDisp":"1992-","dateIssuedKey":"1992","publisherPlace":"Amsterdam [u.a.] ; [Erscheinungsort nicht ermittelbar]","publisher":"Elsevier ; Pergamon Press"}],"note":["Gesehen am 21.03.24","Ungezählte Beil.: Supplement"],"language":["eng"],"type":{"media":"Online-Ressource","bibl":"periodical"},"title":[{"title_sort":"European journal of cancer","title":"European journal of cancer"}],"corporate":[{"display":"European Organization for Research on Treatment of Cancer","role":"isb"},{"display":"European Association for Cancer Research","role":"isb"},{"display":"European School of Oncology","role":"isb"}],"pubHistory":["28.1992 -"],"titleAlt":[{"title":"EJC online"}],"part":{"year":"2021","pages":"41-48","extent":"8","text":"152(2021) vom: Juli, Seite 41-48","volume":"152"},"id":{"zdb":["1468190-0"],"issn":["1879-0852"],"eki":["266883400"]}}],"person":[{"family":"Salzmann","given":"Martin","role":"aut","display":"Salzmann, Martin"},{"display":"Tosev, Georgi","given":"Georgi","role":"aut","family":"Tosev"},{"display":"Heck, Melanie","role":"aut","given":"Melanie","family":"Heck"},{"display":"Schadendorf, Dirk","family":"Schadendorf","given":"Dirk","role":"aut"},{"display":"Maatouk, Imad","role":"aut","given":"Imad","family":"Maatouk"},{"display":"Enk, Alexander","given":"Alexander","role":"aut","family":"Enk"},{"role":"aut","given":"Martin","family":"Hartmann","display":"Hartmann, Martin"},{"display":"Hassel, Jessica C.","given":"Jessica C.","role":"aut","family":"Hassel"}],"id":{"eki":["1772152374"],"doi":["10.1016/j.ejca.2021.04.031"]},"name":{"displayForm":["Martin Salzmann, Georgi Tosev, Melanie Heck, Dirk Schadendorf, Imad Maatouk, Alexander H. Enk, Martin Hartmann, Jessica C. Hassel"]}} 
SRT |a SALZMANNMAMALEFERTIL2920